Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00502073 · ClinicalTrials.gov registry record · Phase 3
Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)
A Phase 3 study of Dry Eye Syndromes, sponsored by Sirion Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00502073 is a Phase 3 study of Dry Eye Syndromes that has completed, run by Sirion Therapeutics. The trial reports 1 study location across 1 state.
The verdict
NCT00502073, a Phase 3 study of Dry Eye Syndromes, has completed, sponsored by Sirion Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
Conditions Studied
Interventions
- DRUG cyclosporine
Study Locations (1)
Maine
- Eye Center Northeast - Bangor
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00502073
The ClinicalTrials.gov registry entry for NCT00502073 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Sirion Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dry Eye Syndromes appearing as the primary indexed condition, and to 1 intervention - of which cyclosporine is the first listed.
NCT00502073 reports 1 study location spanning 1 distinct geographic area - top geographies include Maine.
Frequently Asked Questions
What is clinical trial NCT00502073 about?
NCT00502073 is a clinical study titled "Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)". The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
What is the current status of trial NCT00502073?
This trial is currently completed. It is a Phase 3 study.
What conditions does trial NCT00502073 study?
This clinical trial studies the following conditions: Dry Eye Syndromes.
What interventions are being tested in trial NCT00502073?
The interventions under investigation include: cyclosporine (DRUG).
Who is sponsoring clinical trial NCT00502073?
This trial is sponsored by Sirion Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00502073 being conducted?
This trial has 1 study location across Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
COMPLETED · Phase 3
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Efficacy of OmegaBoost to Increase Omega-3 Levels in Healthy Individuals
ACTIVE NOT RECRUITING · NA
-
Evaluation of Dry Eye Symptoms in CAE With Application of Intranasal Neurostimulation
COMPLETED · NA
-
TrueTear in Sjogren's Disease Patients
COMPLETED · NA
-
ACCURATE Study for Subjects With Dry Eyes
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.